5 Results for: created: (01/2018 to 01/2018)

People

  1. Motzer
    Motzer
  2. Bajorin
    Bajorin
  3. Capanu
    Capanu
  4. Do
    Do
  5. Hollywood
    Hollywood
  6. Kelsen
    Kelsen
  7. Lee
    Lee
  8. Lowery
    Lowery
  9. Maynard
    Maynard
  10. Moynahan
    Moynahan

Groups

  1. Department of Medicine (5)
  2. Solid Tumor Oncology Division (5)
  3. Genitourinary Oncology Service (4)
  4. Advanced Practice Providers (1)
  5. Biostatistics Service (1)
  6. Body Imaging Service (1)
  7. Breast Medicine Service (1)
  8. Center for Pancreatic Cancer Research (1)
  9. Clinical Genetics Service (1)
  10. Department of Pathology and Laboratory Medicine (1)
  1. "European Journal of Cancer"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (1)
Groups
  1. Department of Medicine (5)
  2. Solid Tumor Oncology Division (5)
  3. Genitourinary Oncology Service (4)
  4. Advanced Practice Providers (1)
  5. Biostatistics Service (1)
  6. Body Imaging Service (1)

More Groups

People
  1. Robert Motzer (3)
  2. David Kelsen (1)
  3. Dean Bajorin (1)
  4. Eileen O'Reilly (1)
  5. Ellen Hollywood (1)
  6. Erin Salo-Mullen (1)

More People

Years
  1. 2018 (1)
  2. 2017 (4)
Publications
  1. European Journal of Cancer (5)
Publishers
  1. Elsevier Inc. (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma
    Journal Article

    Lowery, M. A.; Kelsen, D. P.; Capanu, M.; Smith, S. C.; Lee, J. W.; Stadler, Z. K.; Moore, M. J.; Kindler, H. L.; Golan, T.; Segal, A.; more...
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Effect of prior systemic therapy on clinical outcomes with cabozantinib vs everolimus in advanced renal cell carcinoma: Results from the phase 3 METEOR study
    Meeting Abstract

    Grande, E.; Choueiri, T. K.; Motzer, R. J.; Escudier, B.; Pal, S.; Kollmannsberger, C.; Pikiel, J.; Gurney, H.; Rha, S. Y.; Park, S. H.; more...
    European Journal of Cancer (2017)

    Fulltext@MSK | Save
  • Pembrolizumab vs investigator-choice chemotherapy for previously treated advanced urothelial cancer: Phase 3 KEYNOTE-045 study
    Meeting Abstract

    Necchi, A.; Bellmunt, J.; De Wit, R.; Vaughn, D.; Fradet, Y.; Lee, J. L.; Fong, L.; Vogelzang, N.; Climent, M.; Petrylak, D.; more...
    European Journal of Cancer (2017)

    Fulltext@MSK | Save
  • Overall survival results from the phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma (METEOR)
    Meeting Abstract

    Schmidinger, M.; Motzer, R. J.; Powles, T.; Escudier, B.; Tannir, N. M.; Mainwaring, P. N.; Rini, B. I.; Hammers, H. J.; Donscov, F.; Roth, B.; more...
    European Journal of Cancer (2017)

    Fulltext@MSK | Save
  • Efficacy of cabozantinib vs everolimus in advanced renal cell carcinoma with bone metastases: Results from the phase 3 METEOR study
    Meeting Abstract

    Bracarda, S.; Choueiri, T. K.; Powles, T.; Motzer, R. J.; Olencki, T.; Frontera, O. A.; Oudard, S.; Rolland, F.; Tomczak, P.; Castellano, D.; more...
    European Journal of Cancer (2017)

    Fulltext@MSK | Save